Patent · US Active

Antibodies against growth differentiation factor 15 and uses thereof

US11312766B2 · kind B2 · utility

0Cited by

0References

20Claims

0Family size

Assignee

Novartis AG · CH

Inventors

Hong Chen · Kaohsiung, TW
Rajiv Chopra · Toronto, CA
Seung Wan Hahm · Newton, US
Norio Hamamatsu · Belmont, US
Ryan Scott STREEPER · Needham, US
Mei Xu · Seattle, US

Key dates

Filing date	Apr 26, 2017
Grant date	Apr 26, 2022
Priority date	—
Expiry date	Apr 26, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided herein are monoclonal antibodies (e.g., human antibodies) binding to human Growth Differentiation Factor 15 protein (hereinafter, sometimes referred to as “GDF15”), and pharmaceutical compositions and methods of treatment comprising the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.